abnormal skeleton development_Cbfb<tm1Spe>/Cbfb<tm2.1Spe>

http://metadb.riken.jp/0002113I129S4SvJaeCbfbtm1SpeCbfbtm21SpeCbfbtm1SpeCbfbtm21Spe

abnormal skeleton development_Cbfb<tm1Spe>/Cbfb<tm2.1Spe>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• core binding factor beta
  http://metadb.riken.jp/db/mgi_rdf/MGI:99851

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Cbfb<tm1Spe>/Cbfb<tm2.1Spe>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Cbfb<tm1Spe>|Cbfb<tm2.1Spe>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S4/SvJae

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal skeleton development
  http://purl.obolibrary.org/obo/MP_0002113

文献

http://purl.org/net/cito/citesAsAuthority

• Laleh. Talebian, et.al., T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage., Blood, 2007, 109
  http://rdf.ncbi.nlm.nih.gov/pubmed/16940420